Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dermalo
- Development stage
- Unknown
- Lead developer
- Dermal Laboratories
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Dermalo is a topical bath emollient developed by Dermal Laboratories, a subsidiary of the Diomed Group, for the management of dry skin conditions such as eczema, dermatitis, and ichthyosis. The formulation is a combination of liquid paraffin, isopropyl myristate, and acetylated lanolin alcohols. It is designed to be added to bath water or applied directly to wet skin, where it forms an occlusive film on the skin surface. This oily layer acts as a physical barrier that prevents the evaporation of water from the stratum corneum, thereby restoring the skin's natural moisture levels, soothing irritation, and improving skin barrier function.
- Brand names
- DermaloDermalo Bath Emollient
- Other names
- Dermalo topical formulation
Beyond the preview
Go deeper on Dermalo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dermalo.